Treace
Manufacturing · Florida, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
100 Palmetto Park Pl, Ponte Vedra, Flori...Phone Number
(904) 373-5940Website
www.treace.comRevenue
$207.3 MillionStock Symbol
TMCIIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Treace
Treace Medical Concepts is an orthopedic medical device company focused on the surgical correction of bunions and related midfoot deformities. Its flagship Lapiplasty 3D Bunion Correction System and associated implants, instruments, and surgical techniques are designed to correct bunions in three dimensions at the root cause, along with complementary products addressing related foot and ankle pathologies. Treace sells primarily to orthopedic surgeons and hospitals/ASCs in the U.S. and select international markets.Explore more
Treace Org Chart
Get the full picture
Sign in to uncover key details.
Show More
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Treace your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Treace had a recent Job posting/layoffs
Product Launch: Get notified when Treace launches new products
Treace, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Treace has new funding data
Check if Treace has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Treace recently announced quarterly report
Check out if Treace is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Treace
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined Treace as Masked Content
Find more new buyers
Compare Similar Companies to Treace
Compare insights from companies similar to Treace, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Treace is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Treace is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Treace.
Treace financials insights
Gather financial insights about Treace, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Private Equity
$7M
2017
Debt
$2.1M
Private Equity
$5.9M
2020
Debt
$1M
2021
Share Placement
$191M
2022
Debt
$150M
2025
Debt
$175M
Treace Tech Stack
A closer look at the technologies used by Treace
See more technologies
Most Recent Scoops
Person-Based
Earnings, Finance
Person-Based
Lawsuits, Legal Affairs
Hiring Plans
Treace has more open roles in Finance than it has had at any time in the past 9 months.
Hiring Plans
Project
Product Development
Treace News & Media
Treace to Report Second Quarter 2026 Financial Results on August 7, 2026
PONTE VEDRA, Fla., July 24, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today announced that it will release financial results for the second quarter 2026 before the start of trading on Friday, August 7, 2026. Company management will host a conference call to discuss financial results beginning at 8:00 amTreace Announces First Surgical Case with the HyperPlate™ XM Dynamic Compression Locking Implant System
New portfolio addition to drive further penetration into incremental procedures throughout the foot and ankle; strengthens Treace’s comprehensive suite of technologies for its growing customer base New portfolio addition to drive further penetration into incremental procedures throughout the foot and ankle; strengthens Treace’s comprehensive suite of technologies for its growing customer baseTreace to Present at the Sidoti Small Cap Conference
PONTE VEDRA, Fla., June 11, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today announced it will present at the Sidoti Small Cap Conference, Thursday, June 18, 2026, beginning at approximately 1:45 pm ET.Treace Medical Concepts Q1 Earnings Call Highlights
Treace Medical Concepts (NASDAQ:TMCI) reaffirmed its full-year 2026 revenue outlook after reporting a first-quarter revenue decline, as management said new product adoption is helping drive procedure volume momentum despite pricing and mix headwinds. On the company’s first-quarter earnings call, Ch
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Treace
Sign Up For FreeTo access detailed company insights
Treace Medical Concepts is an orthopedic medical device company focused on the surgical correction of bunions and related midfoot deformities. Its flagship Lapiplasty 3D Bunion Correction System and associated implants, instruments, and surgical techniques are designed to correct bunions in three dimensions at the root cause, along with complementa... Read More
